Table 1.
Baseline characteristics of the subjects for microarray analysis
| Group | Sample NO. | Pathology | Age | HPV type | TCT |
|---|---|---|---|---|---|
| 1 | 0000134 | Normal cervix | 46 | 16 | NILM |
| 1 | 2100365 | Normal cervix | 44 | 16 | NILM |
| 1 | 2100071 | Normal cervix | 47 | 16 | NILM |
| 1 | 2100371 | Normal cervix | 43 | 16 | NILM |
| 1 | 2100222 | Normal cervix | 45 | 16 | NILM |
| 2 | 0000219 | CIN3 | 45 | 16 | ASCUS |
| 2 | 2100218 | CIN3 | 50 | 16 | HSIL |
| 2 | 2100209 | CIN3 | 46 | 16 | ASC-H |
| 2 | 0000043 | CIN3 | 42 | 16 | ASCUS |
| 2 | 2100399 | CIN3 with gland involvement | 50 | 16 | ASC-H |
| 2 | 2100046 | CIN3 with gland involvement | 48 | 16 | NILM |
| 2 | 0000126 | CIN3 | 43 | 16 | LSIL |
| 2 | 2100005 | CIN3 | 46 | 16 | ASCUS |
| 2 | 0000179 | CIN3 | 41 | 16 | ASCUS |
| 2 | 2100068 | CIN3 | 43 | 16 | NILM |
| 3 | 2100279 | SCC G2 | 48 | 16 | SCC |
| 3 | 2100387 | SCC G2 | 49 | 16 | HSIL |
| 3 | 2100418 | SCC G2 | 46 | 16 | ASCUS |
| 3 | 0000266 | SCC G2 | 50 | 16 | ASCUS |
| 3 | 0000172 | SCC G2 | 44 | 16 | SCC |
| 3 | 2100125 | SCC G2 | 46 | 16 | ASCUS |
| 3 | 2100385 | SCC G2 | 50 | 16 | HSIL |
| 3 | 0000048 | SCC G2 | 47 | 16 | NILM |
| 3 | 0000104 | SCC G2 | 50 | 16 | ASCUS |
| 3 | 2100290 | SCC G2 | 49 | 16 | SCC |
TCT, ThinPrep cytologic test; NILM, negative for intraepithelial lesion or malignancy; ASCUS, atypical squamous cells of undetermined significance; ASC-H, atypical cells of undetermined significance, cannot exclude a high-grade squamous intraepithelial lesion; LSIL, low-grade squamous intraepithelial lesion; HSIL, high-grade squamous intraepithelial lesion; SCC, squamous cell carcinoma.